On Wednesday afternoon, 16 October 2024, Brazil delivered the following statement on transfer of technology at the 36th session of the WIPO Standing Committee on the Law of Patents (SCP). Intervention by the Delegate of Brazil at the World Intellectual… Continue Reading
Title: Best and worst practices for limitations and exceptions to patent rights Date: Thursday, 17 October 2024 Time: 13:30 CEST to 15:00 CEST Location: Room B, WIPO Registration link: https://wipo-int.zoom.us/meeting/register/u5Mtf-6vqz0jGdWIE2AObIjgN86Xuy4yqaKi Conveners: Innovarte and Knowledge Ecology International (KEI) On the margins… Continue Reading
On October 3, 2023, Knowledge Ecology International (KEI) sent a letter to the FDA asking the agency to publish its historical Orange Book data. The Orange Book identifies patent and exclusivity data for FDA approved drug products. The FDA publicly… Continue Reading
KEI2HHS19Sep2024 September 19, 2024 Emily Bleimund, JD, MA Director, Office of Trade and Health U.S. Department of Health and Human Services Steven T. Smith National Institute of Allergy and Infectious Diseases (NIAID) Representative, Geneva, Switzerland Dear Emily and Steven, I… Continue Reading
The WHO has shared the end of day September 16, 2024 version of the negotiating text for a WHO pandemic agreement. who-pandemic-agreement-16Sep-17.30
On Thursday, 12 September 2024, non-State actors in official relations and relevant stakeholders were invited to join a “brief open session at the beginning of the day.” In advance of Thursday’s discussions on Article 13 (Supply chain and logistics) and… Continue Reading
The USPTO has a request for comment on the need for a statutory experimental use exception for patents. (89 FR 53963). The USPTO uploads the comments to Regulations.Gov, docket PTO-C-2024-0023. KEI filed comments on September 10, 2024: KEI-Experimental-use-exception-10Sept2024 September 10,… Continue Reading
On Monday afternoon, 9 September 2024, Knowledge Ecology International (KEI) delivered this statement on the complementarity and coherence between the amended International Health Regulations (2005), adopted by the Seventy‑seventh World Health Assembly, and the proposal for the WHO Pandemic Agreement… Continue Reading
On Monday afternoon, 9 September 2024, Knowledge Ecology International (KEI) delivered this statement on the legal architecture of the proposal for the WHO Pandemic Agreement. KEI has an open mind regarding the appropriate nature of the instrument or instruments for… Continue Reading
On September 3, 2024, Knowledge Ecology International (KEI) submitted comments to the NIH regarding the “Prospective Grant of an Exclusive Patent License: Dimethyl Synaptamide for the Treatment of Autoimmune Disorders and Inflammatory Diseases” (89 FR 66730). The Federal Register notice… Continue Reading